With most pharmaceutical companies currently embarking on the same omnichannel strategy, from a doctor’s perspective, this results in a relentless deluge of emails, webinar invites and promotional material. So, what should pharmaceutical companies and their representatives consider going forward?
![Whitepaper Hero Image 750x435 A](https://www.adg.com.au/wp-content/uploads/2024/03/WHITEPAPER_HERO_IMAGE_750x435_A.png)